|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2011-4-21
|
|
pubmed:abstractText |
Edwardsiella tarda, a catalase-positive bacillus widely distributed throughout nature, is generally susceptible to trimethoprim/sulfamethoxazole. We describe osteomyelitis due to trimethoprim/sulfamethoxazole-resistant E. tarda in a patient with chronic granulomatous disease (CGD). Once E. tarda acquires antibiotic resistance, infected CGD patients may develop severe infections with unforeseeable consequences.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1439-0973
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
39
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
171-3
|
|
pubmed:meshHeading |
pubmed-meshheading:21246245-Adolescent,
pubmed-meshheading:21246245-Anti-Bacterial Agents,
pubmed-meshheading:21246245-Drug Resistance, Bacterial,
pubmed-meshheading:21246245-Edwardsiella tarda,
pubmed-meshheading:21246245-Enterobacteriaceae Infections,
pubmed-meshheading:21246245-Granulomatous Disease, Chronic,
pubmed-meshheading:21246245-Humans,
pubmed-meshheading:21246245-Infant, Newborn,
pubmed-meshheading:21246245-Leg,
pubmed-meshheading:21246245-Magnetic Resonance Imaging,
pubmed-meshheading:21246245-Male,
pubmed-meshheading:21246245-Osteomyelitis,
pubmed-meshheading:21246245-Trimethoprim-Sulfamethoxazole Combination
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Osteomyelitis due to trimethoprim/sulfamethoxazole-resistant Edwardsiella tarda infection in a patient with X-linked chronic granulomatous disease.
|
|
pubmed:affiliation |
Department of Human Genetics, National Center for Child Health and Development, Tokyo, Japan. kawai-t@ncchd.go.jp
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
